HBV markers (HBsAg, HBSAb, HBCAb in 160 medical students at Kenyatta National Hospital.

dc.contributor.author	Lule, G.N,
dc.contributor.author	Okoth, F
dc.contributor.author	Ogutu, E.O
dc.contributor.author	Mwai, S.J.
dc.date.accessioned	2013-04-26T10:54:20Z
dc.date.available	2013-04-26T10:54:20Z
dc.date.issued	1989
dc.identifier.citation	East Afr Med J. 1989 May;66(5):315-8	en
dc.identifier.uri	http://hinari-gw.who.int/whalecomwww.ncbi.nlm.nih.gov/whalecom0/pubmed/2791927
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/17058
dc.description.abstract	In an exercise to study the immunogenicity and reactogenicity of the Engerix B vaccine, 160 medical students were screened for Hepatitis B Markers (HBsAg, HBsAb and HBcAb) with a view to vaccinating those that were negative. 18% were HBsAg + ve, 33% were HBsAb + ve and 38% were positive for the HBcAb. These figures were extremely high and obviated the need to vaccinate the students as they begin their clinical years.	en
dc.language.iso	en	en
dc.title	HBV markers (HBsAg, HBSAb, HBCAb in 160 medical students at Kenyatta National Hospital.	en
dc.type	Article	en